Sign in
4

Changes in Ownership

Sarepta Therapeutics, Inc. Filed Acc 0001209191-19-016029

Director acquired 1,633 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

BEHRENS M KATHLEEN · Director

Table I: Non-derivative

1 line
Date Transaction Shares Owned after D/I
2019-03-04 Grant or award : show line 1 in the form +1,633 118,167 D

Table II: Derivative

1 line
Date Transaction Shares Exercise Expires Underlying Owned after D/I
2019-03-04 Grant or award : show line 2 in the form Stock option (right to buy) +3,213 $145.48 2029-03-04 3,213 3,213 D
Loading xslF345X03/doc4.xml…